From October 1, 2015 to December 31, 2015, the company has repurchased 3,045,600 shares, representing 0.29% for $252.91 million. With this, the company has completed the repurchase of 32,384,700 shares, representing 3.02% for $2,048.91 million under the buyback announced on October 3, 2013.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
945.2 USD | -0.55% |
|
+1.36% | +62.14% |
02:35pm | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.14% | 856B | |
+38.95% | 631B | |
-4.05% | 359B | |
+15.41% | 325B | |
+9.54% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+16.34% | 177B | |
+2.40% | 165B | |
+2.41% | 126B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Tranche Update on Eli Lilly and Company's Equity Buyback Plan announced on October 3, 2013.